Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: A nested case-control study in the Spanish EPIC cohort

Journal of Nutritional Biochemistry

Volumn 22, Issue 5, 2011, Pages 487-494

  Corella, Dolores ^a   Portolés, Olga ^a   Arriola, Larraitz ^b   Chirlaque, María Dolores ^c   Barrricarte, Aurelio ^a,d   Francés, Francesc ^a   Huerta, José María ^c   Larrañaga, Nerea ^b   Martínez, Carmen ^e   Martinez Camblor, Pablo ^b   Molina, Esther ^e   Navarro, Carmen ^c   Quirós, Jose R ^f   Rodríguez, Laudina ^f   Sánchez, María José ^e   Ros, Emilio ^a   Sala, Nuria ^g   González, Carlos A ^a,b,g   Moreno Iribas, Concepción ^b,d,h  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^d INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^e ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^f Public Health and Health Planning Directorate   (Spain)

^g CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Alcohol; APOE; LDL C; Nutrigenetics; Saturated fat

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; DNA POLYMORPHISM; FAT INTAKE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; SPAIN;

ADULT; AGED; ALCOHOL DRINKING; ALLELES; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; CORONARY DISEASE; DIET; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS; FEMALE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK FACTORS; SPAIN;

EID: 79954602831     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.04.003     Document Type: Article

References (50)

1. Arnett D.K., Baird A.E., Barkley R.A., et al. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation. 2007, 115:2878-2901. American Heart Association Council on Epidemiology and Prevention; American Heart Association Stroke Council; Functional Genomics and Translational Biology Interdisciplinary Working Group.
2. Kris-Etherton P.M., Krummel D., Russell M.E., Dreon D., Mackey S., Borchers J., et al. The effect of diet on plasma lipids, lipoproteins, and coronary heart disease. J Am Diet Assoc 1988, 88:1373-1400.
3. Hu F.B., Stampfer M.J., Manson J.E., et al. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 1999, 70:1001-1008.
4. Xu J., Eilat-Adar S., Loria C., Goldbourt U., Howard B.V., Fabsitz R.R., et al. Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr 2006, 84:894-902.
5. Howard B.V., Van Horn L., Hsia J., et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295:655-666.
6. Ravnskov U. The questionable role of saturated and polyunsaturated fatty acids in cardiovascular disease. J Clin Epidemiol 1998, 51:443-460.
7. Lovegrove J.A., Gitau R. Personalized nutrition for the prevention of cardiovascular disease: a future perspective. J Hum Nutr Diet 2008, 21(4):306-316.
8. Ordovas J.M. Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc 2006, 106:1074-1081.
9. Wilson P.W., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A., Schaefer E.J., et al. alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994, 272:1666-1671.
10. Song Y., Stampfer M.J., Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004, 141:137-147.
11. Bennet A.M., Di Angelantonio E., Ye Z., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298:1300-1311.
12. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988, 8:1-21.
13. Eichner J.E., Dunn S.T., Perveen G., Thompson D.M., Stewart K.E., Stroehla B.C. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 2002, 155:487-495.
14. Muendlein A., Saely C.H., Marte T., et al. Synergistic effects of the apolipoprotein E epsilon3/epsilon2/epsilon4, the cholesteryl ester transfer protein TaqIB, and the apolipoprotein C3 -482 C>T polymorphisms on their association with coronary artery disease. Atherosclerosis 2008, 199:179-186.
15. Granér M., Kahri J., Varpula M., et al. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 2008, 18:271-277.
16. Stengård J.H., Pekkanen J., Ehnholm C., Nissinen A., Sing C.F. Genotypes with the apolipoprotein epsilon4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Hum Genet 1996, 97:677-684.
17. Keavney B., Palmer A., Parish S., et al. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol 2004, 33:1002-1013. International Studies of Infarct Survival (ISIS) Collaborators.
18. Talmud P.J., Lewis S.J., Hawe E., et al. No APOEepsilon4 effect on coronary heart disease risk in a cohort with low smoking prevalence: the Whitehall II study. Atherosclerosis. 2004, 177:105-112.
19. Volcik K.A., Barkley R.A., Hutchinson R.G., et al. Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants. Am J Epidemiol 2006, 164:342-348.
20. Loew M., Hoffmann M.M., Hahmann H., März W., Rothenbacher D., Brenner H. Smoking, apolipoprotein E genotype, and early onset of coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005, 12:268-270.
21. Marshall H.W., Morrison L.C., Wu L.L., et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation. 1994, 89:567-577.
22. Kolovou G.D., Daskalova D.Ch., Hatzivassiliou M., et al. The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population - implications for the interpretation of similar studies. Angiology 2003, 54:51-58.
23. Mamotte C.D., Burke V., Taylor R.R., van Bockxmeer F.M. Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes. Eur J Intern Med 2002, 13:250-255.
24. Koch W., Hoppmann P., Schömig A., Kastrati A. Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample. Int J Cardiol 2008, 125:116-117.
25. Vaisi-Raygani A., Rahimi Z., Nomani H., Tavilani H., Pourmotabbed T. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin Biochem 2007, 40:1150-1156.
26. Lahoz C., Schaefer E.J., Cupples L.A., et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001, 154:529-537.
27. Tso T.K., Park S., Tsai Y.H., Williams G., Snook J.T. Effect of apolipoprotein E polymorphism on serum lipoprotein response to saturated fatty acids. Lipids 1998, 33:139-148.
28. Loktionov A., Scollen S., McKeown N., Bingham S.A. Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals. Br J Nutr 2000, 84:885-890.
29. Campos H., D'Agostino M., Ordovás J.M. Gene-diet interactions and plasma lipoproteins: role of apolipoprotein E and habitual saturated fat intake. Genet Epidemiol 2001, 20:117-128.
30. Yang Y., Ruiz-Narvaez E., Kraft P., Campos H. Effect of apolipoprotein E genotype and saturated fat intake on plasma lipids and myocardial infarction in the Central Valley of Costa Rica. Hum Biol 2007, 79:637-647.
31. Gylling H., Miettinen T.A. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J Lipid Res 1992, 33:1361-1371.
32. Sarkkinen E., Korhonen M., Erkkilä A., Ebeling T., Uusitupa M. Effect of apolipoprotein E polymorphism on serum lipid response to the separate modification of dietary fat and dietary cholesterol. Am J Clin Nutr 1998, 68:1215-1222.
33. Savolainen M.J., Rantala M., Kervinen K., et al. Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. Atherosclerosis 1991, 86:145-152.
34. Pasagian-Macaulay A., Aston C.E., Ferrell R.E., McAllister A.E., Wing R.R., Kuller L.H. A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus. Atherosclerosis 1997, 132:221-227.
35. Corella D., Tucker K., Lahoz C., et al. Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 2001, 73:736-745.
36. Djoussé L., Pankow J.S., Arnett D.K., Eckfeldt J.H., Myers R.H., Ellison R.C. Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2004, 80:1639-1644.
37. González C.A., Navarro C., Martínez C., et al. The European Prospective Investigation on Diet, Cancer, and Health (EPIC) in Spain. Group EPIC of Spain. Med Clin (Barc) 1994, 102:781-785.
38. Riboli E., Kaaks R. The EPIC project: rationale and study design. Int J Epidemiol 1997, 26:S6-S14.
39. Riboli E., Hunt K.J., Slimani N., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002, 5:1113-1124.
40. Danesh J., Saracci R., Berglund G., et al. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Eur J Epidemiol 2007, 22:129-141.
41. Luepker R.V., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003, 108:2543-2549.
42. Wareham N.J., Jakes R.W., Rennie K.L., et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr 2003, 6:407-413.
43. Relative validity and reproducibility of a diet history questionnaire in Spain. I. Foods. Int J Epidemiol 1997, 26:S91-S99. EPIC Group of Spain.
44. Relative validity and reproducibility of a diet history questionnaire in Spain. II. Nutrients. Int J Epidemiol 1997, 26:S100-S109. EPIC Group of Spain.
45. Slimani N., Torrent M., Farriols N., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): food composition tables - Spain 1991, International Agency for Research on Cancer, Lyon.
46. Pearson T.A. Alcohol and heart disease. Circulation 1996, 94:3023-3025.
47. Agudo A., Goñi F., Etxeandia A., et al. Polychlorinated biphenyls in Spanish adults: determinants of serum concentrations. Environ Res 2009, 109:620-628.
48. Francés F., Portolés O., Sorlí J.V., Guillén M., González J.I., Corella D. Single tube optimisation of APOE genotyping based on melting curve analysis. Clin Biochem 2008, 41:923-926.
49. Corella D., Guillén M., Sáiz C., et al. Environmental factors modulate the effect of the APOE genetic polymorphism on plasma lipid concentrations: ecogenetic studies in a Mediterranean Spanish population. Metabolism 2001, 50:936-944.
50. Mukamal K.J., Chung H., Jenny N.S., et al. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. J Am Geriatr Soc 2006, 54:30-37.